RussianPatents.com

Method for production of bacterial concentrate and its application as probiotic biologically active food additive

Method for production of bacterial concentrate and its application as probiotic biologically active food additive
IPC classes for russian patent Method for production of bacterial concentrate and its application as probiotic biologically active food additive (RU 2541778):
Another patents in same IPC classes:
Method for production of dry complex starter for kvass fermentation / 2541758
Method involves preparation of a saccharified brew by way of first grade wheat flour and wheat bran mixing at a ratio of 1:1, the produced mixture brewing with 85-90°C water, maintenance during 45-60 minutes, the mixture cooling to 65-67°C, saccharifying with non-fermented barley or rye malt in an amount of 10% of the mixture weight during 60-90 minutes, yeast autolysate introduction in an amount of 0.1% of the mixture weight to produce a nutritional substrate. Then one performs the substrate weighing out into three fermentative vessels with quadruplication of weighed portion equal to 50 g:200 g:800 g, respectively, three-times' autoclaving with a 24 hours' interval under 1.5 atm during 60 minutes, lactic acid bacteria reproduction in the prepared substrate in three-phase propagation cycle till the final acidity of sodium hydroxide solution with concentration equal to 1 mole/dm3 is equal to16-18 cm3 per 100 cm3 of the brew; the lactic acid bacteria source is represented by prebiotic preparations "Lactobacterin" or "Bifidumbacterin" "Evitalia" or a complex consisting of the said three preparations that are dissolved in 5 cm3 of a sterile physiological solution with each of them transferred into the cooled sterile saccharified brew in an amount of 1 dose of the preparation which is equal to 2×109, 107 and 1.5-2.0×109 CFU, respectively, per 50 g of the substrate. The inoculated nutrient medium is incubated (first phase) during 24 hours at a temperature of 37°C; then one performs the second and the third phases of the propagation cycle by way of dilution of the ripe starter of the previous phase in a four-fold quantity of the sterile saccharified brew for the subsequent phase. Incubation of the subsequent phases of the propagation cycle is performed during 24 hours at a temperature of 37°C till acidity of sodium hydroxide solution with concentration equal to 1 mole/dm3 is 16-18 cm3 per 100 cm3 of the brew. Then one performs the phases mixing with potato starch in an amount equal to the starter weight and Saccharomyces cerevisiae pressed bakery yeast in a dose of 5 g/100 dm3 of the kvass wort, the produced mass drying in a sterile air flow at room temperature till moisture content is equal to 13-14%. The total time of the saccharified brew fermentation is equal to 72 hours.
Nutrient culture medium for swine erysipelas strain erysipelothrix rhuisipathie Nutrient culture medium for swine erysipelas strain erysipelothrix rhuisipathie / 2541454
Nutrient culture medium for swine erysipelas strain Erysipelothrix rhuisipathie refers to general biotechnology and veterinary microbiology. As a nitrogenous nutrition source, the nutrient medium contains a mixture of fish autolysate and alkaline mussel hydrolysate in the following proportions: alkaline mussel hydrolysate 20-50%; fermentation peptone 1%; potassium phosphate 0.3%; sodium phosphate 1.8%; fish autolysate - the rest.
Method of obtaining bacterial concentrate of bifidobacteria in liquid form Method of obtaining bacterial concentrate of bifidobacteria in liquid form / 2540022
Invention relates to biotechnology and medical industry and can be used in production of bacterial concentrates, biologically active food additives, fermented food products. Method of obtaining bacterial concentrate of bifidobacteria in liquid form includes preparation of nutritional medium with addition of growth components based on clarified cottage cheese whey or on water base with addition of up to 1.5% of glucose, or on soybean whey with addition of lactose in amount 1%. Strain of bifidobacteria B. bifidum 83, activated with β-halactosidase, is introduced into prepared nutritional medium in amount 3-5%, biomass is grown, cooled, poured in containers.
Barley-and-milk starter preparation method / 2540015
Invention relates to a starter preparation method. The method envisages preparation of the substrate of a mixture of barley flour and dry milk, mixed with water at a ratio of 1:3-1:4 and a temperature of 75-80°C, the substrate cooling, introduction of a mixture of amylase and xylanase enzyme preparations, maintenance at a temperature of 48-50°C during 90-120 min, the barley-and-milk hydrolysate cooling to 32-35°C, introduction of Linex combined preparation (1 capsule per 100 g of the barley-and-milk hydrolysate) and pressed bakery yeast (0.1% of the barley-and-milk hydrolysate total weight), the barley-and-milk starter incubation during 18-20 h at a temperature of 32-35°C, until titratable acidity is 10-12 degrees.
Method for preparing pertussis component of combined vaccines Method for preparing pertussis component of combined vaccines / 2540014
Invention refers to biotechnology and concerns a method for preparing a pertussis component of complex vaccines. The presented method involves the B. pertussis culture growth on dense Bordet-Gengou and/or CCA nutrient media, the grown colonies selection according to the morphological characteristics, the selected colonies passage, the bacterial mass growth, the culture washout, the extinction reduction of the prepared pertussis suspensions to 10 international optical units, the agglutination reaction to measure agglutinogens 1, 2, 3 and the selection of pertussis suspensions, wherein the agglutinogen content is determined by type-specific serum dilution 1:3200 and more. The detected B. pertussis culture expressing agglutinogens 1, 2, 3 actively after the lyophilisation is used to prepare the pertussis component of complex vaccines.
Strain of lactobacillus delbrueckii, reducing content of cholesterol in blood Strain of lactobacillus delbrueckii, reducing content of cholesterol in blood / 2539785
Group of inventions relates to biotechnology. Claimed is strain of Lactobacillus delbrueckii subspecies lactis CNCM I-3741, reducing content of cholesterol in blood. Strain is applied for obtaining fermented dairy products.
Bacillus subtilis strain capable of splitting sugars and having antagonistic effect on pathogenic and opportunistic pathogenic bacteria and fungi, and use thereof Bacillus subtilis strain capable of splitting sugars and having antagonistic effect on pathogenic and opportunistic pathogenic bacteria and fungi, and use thereof / 2539762
Group of inventions relates to biotechnology. Disclosed is a Bacillus subtilis VKPM V-11353 strain, capable of splitting a wide range of mono- and di-sugars and a wide range antagonistic effect on pathogenic and opportunistic pathogenic bacteria and fungi, which cause diseases in plants and farm animals. Also disclosed are versions of using the Bacillus subtilis VKPM V-11353 strain as a bacterial preservative for silos, for producing agents for normalising intestinal microflora of animal farms and for producing agents for protecting plants from diseases.
Strain of bacteria paenibacillus sp. for obtaining biological product against diseases of wheat caused by phytopathogenic fungi / 2539738
Strain of bacteria Paenibacillus sp. IB-1 has antagonistic activity against phytopathogenic fungi. The strain is deposited in the Russian National Collection of Microorganisms under the registration number VKM B-2823D and can be used to produce the biological product for protection of plants against diseases caused by phytopathogenic fungi.
Strain bacillus thuringiensis var. israelensis № 7-1/23a used as agent for producing preparation having larvicidal activity on blood-sucking mosquitoes / 2539732
Invention refers to biotechnology, namely to protective devices for humans and farm animals against blood-sucking mosquitoes. The strain Bacillus thuringiensis var. israelensis No. 7-1/23A possesses larvicidal properties. The strain Bacillus thuringiensis var. israelensis is deposited in the collection of State Scientific Institution All-Russian Research Institute of Agricultural Microbiology of Russian Agricultural Academy under No. RCAM00626 in the group of spore microorganisms. It can be used in creating a larvicidal biopreparation against blood-sucking mosquitoes.
Method of cleaning soils from oil under conditions of low positive temperatures with psychrotolerant bacteria pseudomonas sp. ib-1.1 / 2539148
Method comprises application into soil of suspension of microbial preparation on the basis of suspension of psychrotolerant bacterial strain Pseudomonas sp. IB - 1.1 with a titre of not less than 2.0·108 CFU/ml.
Method of obtaining bacterial concentrate of bifidobacteria in liquid form Method of obtaining bacterial concentrate of bifidobacteria in liquid form / 2540022
Invention relates to biotechnology and medical industry and can be used in production of bacterial concentrates, biologically active food additives, fermented food products. Method of obtaining bacterial concentrate of bifidobacteria in liquid form includes preparation of nutritional medium with addition of growth components based on clarified cottage cheese whey or on water base with addition of up to 1.5% of glucose, or on soybean whey with addition of lactose in amount 1%. Strain of bifidobacteria B. bifidum 83, activated with β-halactosidase, is introduced into prepared nutritional medium in amount 3-5%, biomass is grown, cooled, poured in containers.
Infant nutritional mixtures containing probiotic microorganisms Infant nutritional mixtures containing probiotic microorganisms / 2539852
Invention relates to infant alimentation field. The infant nutritional mixture, administered to a baby as a single source of nutrition or a single additional source of nutrition as an addition to breast feeding, contains non-replicated probiotic microorganisms brought to a non-replicated condition by way of 71.5-150°C high-temperature treatment during 1-120 sec.
Strain of lactobacillus delbrueckii, reducing content of cholesterol in blood Strain of lactobacillus delbrueckii, reducing content of cholesterol in blood / 2539785
Group of inventions relates to biotechnology. Claimed is strain of Lactobacillus delbrueckii subspecies lactis CNCM I-3741, reducing content of cholesterol in blood. Strain is applied for obtaining fermented dairy products.
Bacillus subtilis strain capable of splitting sugars and having antagonistic effect on pathogenic and opportunistic pathogenic bacteria and fungi, and use thereof Bacillus subtilis strain capable of splitting sugars and having antagonistic effect on pathogenic and opportunistic pathogenic bacteria and fungi, and use thereof / 2539762
Group of inventions relates to biotechnology. Disclosed is a Bacillus subtilis VKPM V-11353 strain, capable of splitting a wide range of mono- and di-sugars and a wide range antagonistic effect on pathogenic and opportunistic pathogenic bacteria and fungi, which cause diseases in plants and farm animals. Also disclosed are versions of using the Bacillus subtilis VKPM V-11353 strain as a bacterial preservative for silos, for producing agents for normalising intestinal microflora of animal farms and for producing agents for protecting plants from diseases.
Nutritional composition containing strains bifidobacterium longum and relieving symptoms of food allergy, especially in infants and children Nutritional composition containing strains bifidobacterium longum and relieving symptoms of food allergy, especially in infants and children / 2539514
Invention refers to microbiology. What is presented is using the strain Bifidobacterium longum NCC 2705 (CNCM-I2618) for preparing a complete nutrient composition used for relieving symptoms of allergy to food in the patients suffering allergies caused by ingestant allergens.
Formulation for treating skin damages / 2539378
Invention refers to medicine and concerns a formulation for treating skin damages containing a therapeutic agent and an ointment base. The therapeutic agent is presented by a microbial cell suspension of nonpathogenic plasmid-free strain E. coli, producing human recombinant peroxiredoxin 6 identical in an amino acid sequence to natural protein. The ointment base contains Vaseline, lanoline, normal saline and phenol as a preserving agent.
Method of prevention of postpartum endometritis in cows / 2538804
Method comprises intravaginal administration of probiotic preparation "Giprolam" (Lactobacillus fermentum 44/1 and Lactococcus lactis subsp. Lactis 574). "Giprolam" is administered for 5-7 days prior to calving daily at a dose of 100 cm3.
Method of treating patients with medication overuse headache / 2538627
Analgesic preparation causing medication overuse headache are withdrawn; a detoxification therapy is conducted; an analgesic alternative is provided; a preventive medication and a behaviour therapy are applied. The preventive medication represents single intramuscular administration of xeomin into temporal muscles in a dose of 25 units in each frontal and occipital muscle in a dose of 12.5 units. The preventive medication follows the detoxification therapy.
Method of treating diabetes mellitus, complicated by accompanying diseases / 2538086
Invention relates to medicine, namely to endocrinology, and deals with treatment of diabetes mellitus, complicated by accompanying diseases, in particular, by parasite invasions. For this purpose electro-activated water solutions of inorganic salts are introduced at the background of antihyperglycemic medications. On first 5 days solution of anolyte (EWS-A) with redox potential (RP) from +700 to +800 mV and with pH from 6.0 to 4.5, after which for 5 days introduced is catholyte solution (EWS-C) with RP from -400 to -600 mV and pH from 9.5 to 10.5; then for 10 days introduced are heated to +36°C - +37°C EWS-C and EWS-A are introduced with their alternation for 24 hours. In case of accompanying parasite invasion, EWS-A in combination with anti-parasitic vegetable medications in form of rectal microclysters for first 5 days of treatment is additionally introduced for first 5 days of treatment. EWS-C in combination with rectal microclysters with probiotic additives is introduced for the following 10 days. In case of detection of Opisthorchida, biltricide is introduced on the 15-th day in dose 75 mg/kg, and duodenal probing with anti-parasitic medication is carried out on the 16-th day. Starting with the 6-th day and to the completion of treatment (21-st day) fermented milk product "Narine" is administered in dose 1 tablespoon 3 times per day 30-40 minutes before meal.
Method for suppressing viability of pathogenic leptospira / 2537271
Invention relates to biotechnology and can be used for suppressing viability of pathogenic leptospira. The method includes growing strains of bacteria "Bacillus subtilis TNP-3-DEP" and "Bacillus subtilis TNP-5-DEP". The grown strains are used for the preparation of a suspension. The obtained suspension, containing the strains of bacteria "Bacillus subtilis TNP-3-DEP" and "Bacillus subtilis TNP-5-DEP" in equal ratios with the concentration of 5×108 CFU in 1 ml, is introduced into vials with cultures of leptospira, incubated at specified process parameters with the registration of a result by the absence of leptospira in the sample.
Strain of lactobacilli lactobacillus paracasei cncm i-2116 (ncc 2461) eliciting ability to prevent intestine colonization with pathogenic microorganisms causing diarrhea, supernatant of its culture and oral agent for prophylaxis and/or treatment of diarrhea-associated disorders Strain of lactobacilli lactobacillus paracasei cncm i-2116 (ncc 2461) eliciting ability to prevent intestine colonization with pathogenic microorganisms causing diarrhea, supernatant of its culture and oral agent for prophylaxis and/or treatment of diarrhea-associated disorders / 2243779
Invention relates to the strain Lactobacillus paracasei CNCM I-2116 used for diarrhea prophylaxis causing by pathogenic microorganisms. Supernatant of this strain culture elicits ability to prevent colonization of intestine with pathogenic microorganisms causing diarrhea also and this strain is designated for preparing agent used for prophylaxis and/or treatment of disorders associated with diarrhea. Agent for oral administration represents therapeutically effective dose of the strain L. paracasei CNCM I-2116 or supernatant of its culture and acceptable foodstuff. Invention provides the enhanced viability of the strain in its applying and effectiveness in prophylaxis of adhesion to intestine cells and invasion to intestine cells of pathogenic microorganisms causing diarrhea.

FIELD: food industry.

SUBSTANCE: inventions group relates to biotechnology and may be used for preparing bacterial preparations applicable as probiotic biologically active additives. The bacterial concentrate production method envisages preparation of a nutritional medium, sterilisation and cooling. Inoculum introduction, cell propagation, bacterial mass separation from culture liquid, dispensing and closuring. Into the nutritional medium composition one introduces cedar or linseed oil of fish or ringed seal fat in an amount of 1-1.5% of the medium weight; the inoculum is represented by a Bifidobacterium longum DK-100 strain. The produced bacterial concentrate is used as a probiotic biologically active food additive.

EFFECT: inventions group allows to recover the digestive tract microflora.

2 cl, 3 tbl, 3 dwg, 5 ex

 

The proposed group of inventions relates to biotechnology and can be used for the preparation of bacterial preparations used as probiotic biologically active additives to food.

A method of obtaining a food product, including the restoration of skimmed milk powder in normalized milk with sugar, heat treatment, cooling, seeding environment yoghurt sourdough probiotic lactic acid bacteria, fermentation, cooling, cooking the juice part with polyunsaturated ω-3 fatty acids and/or free amino acid, mix with yoghurt part in a 1:1 ratio, dispersion and packing (see EN NO. 2282995, A23C 9/12, A23L 1/30 17.12.2004).

The disadvantage of this method is the complexity of the process of obtaining and using only ω-3 polyunsaturated fatty acids in relatively small amounts.

The closest way to the claimed group of inventions on the totality of symptoms is the method of obtaining a bacterial preparation for treatment and prevention of hypercholesterolemia, comprising preparing culture media, sterilization, cooling, introducing an inoculum of Lactobacillus helveticus GCNM 147, increase biomass, branch biomass from the culture fluid, filling, capping, labeling, storage (see EN No. 2072692, A61K 38/46, C12N 1/20, C12R 1/225, 21.01.1997.

The disadvantage of this method is the high acid-forming ability of L. helveticus and not high enough cholesteroldegrading microbial activity, which reduces consumer and probiotic properties.

Thus, in the production of bacterial concentrates the main task is the selection of culture conditions for production of concentrates with high cholesteroldegrading, probiotic and consumer properties.

The technical result that ensures the implementation of the present invention is to improve consumer properties and level of degradation of cholesterol.

This technical result in the implementation of the invention is achieved in that in the method of obtaining a bacterial concentrate, comprising preparing culture media, sterilization, cooling, making inoculum, increase biomass, branch biomass from the culture fluid, bottling, corking, according to the invention in a nutrient medium composition contribute 1-1,5% by weight of the cedar environment or flax oil, or fish or seal oil and sowing carry inoculum of a strain of Bifidobacterium Bifidobacterium longum DK-100.

This technical result is also achieved by the application of the bacterial concentrate, obtained by the claimed method, as probiotic the tion of biologically active food supplements.

Distinctive features of the proposed method are entering into the composition of the nutrient medium cedar or flax oil, or fish or seal oil, the choice of their optimal dose and the use of Bifidobacterium longum DK-100, with marked high cholesteroldegrading activity, consumer and probiotic properties of the concentrate.

In addition, the distinguishing feature of the claimed invention is the use of bacterial concentrate obtained by the proposed method, as probiotic biologically active food supplements.

For the implementation of the proposed method experimental studies were performed.

At the first stage of the research we investigated the effects of polyunsaturated fatty acids on the growth of biomass and the number of viable cells of Bifidobacterium. For this purpose, the inoculum of pure cultures were made in nutrient medium on the basis of cheese whey with the addition of cedar or flax oil, or fish or seal oil in the amount of 0.5-1.5%. The accumulation of biomass of microorganisms was performed by periodic cultivation at 36±1°C. the Growth of the cultures was assessed by the change in optical density at λ=450 nm photocolorimeter. The titer of viable cells of Bifidobacterium was determined by the number of CFU/cm3when seeding cell suspension on Wednesday the MK. For control of bacterial taken the concentrate of the appropriate strain of bacteria without the addition of vegetable oil or animal fat.

The results are shown in table 1 and Fig.1, 2.

Table 1
The effect of PUFA cedar and flax oil, fish and seal oil on the growth of biomass and the number of viable cells of Bifidobacterium
The name of the strain of microorganism The added component The number of added
component %
The optical density, OD The logarithm of the number of cells, CFU/cm3
Duration of cultivation, h
6 12 18 24 6 12 18 24
1 2 3 4 5 6 7 8 9 10 11
Century bifidum 8 control 0,2 0,29 0,46 0,5 7,2 8,4 10,5 11,2
cedar oil 0,5 0,21 0,32 0,49 0,59 7,5 9,8 10,7 11,8
1 0,28 0,35 0,52 0,6 7,9 10,2 10,9 12,1
1,5 0,3 0,39 0,57 0,64 8,2 10,5 11,4 12,2
Flaxseed oil 0,5 0,21 0,33 0,53 0,59 7,8 9,8 10,9 11,9
1 0,29 0,35 0,59 0,63 8,1 10,4 11,2 12,3
1,5 0,31 0,4 0,61 0,66 8,3 10,6 11,8 12,4
fish oil 0,5 0,29 0,33 0,51 0,57 8,4 10 11 12
1 0,31 0,4 0,64 8,4 10,4 11,4 12,4
1,5 0,37 0,45 0,67 0,71 8,5 11 12 the 13.4
seal fat 0,5 0,22 0,33 0,48 0,55 8,3 10 11 12
1 0,28 0,35 0,51 0,58 8,3 10,3 11,3 12,3

11
Continuation of table 1
1 2 3 4 5 6 7 8 9 10 11
Century bifidum 8 seal fat 1,5 0,32 0,38 0,55 0,6 8,4 10,9 11,5 12,4
C. longum DK 100 control 0,2 0,31 0,49 0,54 7,3 8,4 10,5 the 11.6
cedar oil 0,5 0,22 0,33 0,5 0,59 8 10 11 12
1 0,3 0,37 0,53 0,6 8 10,4 12,2
1,5 0,32 0,41 0,6 0,67 8,3 10,6 11,5 12,4
Flaxseed oil 0,5 0,22 0,33 0,59 0,6 8 10 11 12
1 0,3 0,37 0,61 0,67 8,2 10,5 11,3 12,5
1,5 0,33 0,4 0,67 0,7 8,4 10,8 11,9 a 12.7
fish oil 0,5 0,3 0,4 0,54 0,6 8,3 10 12 12,5
1 0,33 0,49 0,68 0,7 8,3 10,3 12 13
1,5 0,38 0,53 0,8 0,89 8,6 11 12,3 13,5
seal fat 0,5 0,28 0,34 0,52 0,6 8,3 10 11 12
1 0,33 0,4 0,55 0,66 8,3 10,4 11,4 12,3
1,5 0,35 0,45 0,68 0,74 8,5 10,9 11,5 12,4
C. longum MM control 0,19 0,28 0,46 0,5 7,2 8 10,5 11,2
cedar oil 0,5 0,21 0,29 0,49 0,57 7,5 the 9.7 10,6 11,8
1 0,26 0,31 0,51 0,59 7,8 the 10.1 10,7 12
1,5 0,29 0,37 0,56 0,62 8,2 10,3 11,2 12,1
Flaxseed oil 0,5 0,21 0,31 0,51 0,58 7,8 the 9.7 10,6 11,8
1 0,26 0,34 0,59 0,6 8 10,2 11,2 12
1,5 0,29 0,38 0,6 0,64 8,2 10,4 the 11.6 12,3
fish oil 0,5 0,23 0,34 0,51 0,6 8,3 10 11 12
1 0,3 0,38 0,6 0,64 8,3 10,3 11,3 12,3
1,5 0,33 0,44 0,63 0,7 9 11 11,5 13
seal fat 0,5 0,21 0,31 0,51 0,6 8,3 10 11 12
1 0,27 0,33 0,55 0,65 8,3 10,3 11,3 12
1,5 0,31 0,38 0,59 0,67 8,4 11 11,4 12,3

As the data presented in table 1, the introduction of pine and flax oil, fish and seal oil in a nutrient medium accelerates the buildup of biomass and the growth of bifidobacteria in the medium compared with the control. The maximum growth of bifidobacteria was observed when the concentration of pine and flax oil, fish and seal oil in the amount of 1.5% (Fig.1 and 2).

These strains possess probiotic properties, but the most intensive growth of biomass of bifidobacteria and the highest number of viable cells is observed when the strain Century longum DK-100 (Fig.1 and 2).

In the next phase of studies investigated the effects of polyunsaturated fatty acids cedar and flax oil, fish and seal fat cholesteroldegrading properties of bifidobacteria.

As a source of cholesterol used purified serum. Cultivation was carried out for 24 hours with double neutralization. During this period followed dynamicauxiliary in a nutrient medium.

The results are shown in table 2 and Fig.3.

Table 2
Cholesteroldegrading activity of bifidobacteria
The name of the strain of microorganism The added component The amount of added component % The cholesterol content in the nutrient medium, mmol/l The level of destruction cholesterol, %
1 2 3 4 5 6 7 8 9 10
Century bifidum 8 control 4,92 4,92 a 4.9 4,76 4,42 3,12 36,59
cedar oil 0,5 4,92 4,92 a 4.83 to 4.52 3,97 2,43 50,61
1 4,92 4,91 4,79 or 4.31 3,84 2,01 59,15
1,5 4,92 a 4.9 4,76 4.26 deaths 3,68 1,72 65,04
Flaxseed oil 0,5 4,92 4,92 4,81 4,46 3,89 2,24 54,47
1 4,92 4,91 4,76 4,27 3,76 1,69 65,65
1,5 4,92 a 4.9 4,71 4,19 3,57 1,41 71,34
fish oil 0,5 4,92 4,87 4,51 3,92 2,97 to 2.06 58,13
1 4,92 4,84 4,39 3,86 2,65 1,81 63,21
1,5 4,92 4,78 4,07 3,54 2,16 1,17 76,22
seal fat 0,5 4,92 a 4.9 4,78 4,53 3,14 2,11 57,11
1 4,92 4,88 4,71 4,42 2,75 1,52 69,11
1,5 4,92 4,85 4,59 4,18 to 2.67 1,24 74,8
C. longum DK 100 control 4,92 4,92 4,87 br4.61 or 4.31 2,95 40,04
cedar oil 0,5 4,92 4,91 4,81 4,47 3,82 2,37 51,83
1 4,92 a 4.9 4,73 4.26 deaths of 3.64 1,85 62,02
1,5 4,92 4,89 to 4.68 4,1 3,35 of 1.57 68,09
Flaxseed oil 0,5 4,92 4,91 4,75 of 4.38 3,76 2,19 55,49
1 4,92 a 4.9 4,69 4,21 3,57 1,54 68,7
1,5 4,92 4,88 br4.61 4,03 3,28 1,26 74,39
fish oil 0,5 4,92 4,86 4,42 3,85 2,84 1,92 60,98
1 4,92 4,81 4,27 3,79 of 2.51 1,48 69,92
1,5 4,92 4,75 4,04 3,51 2,12 1,03 79,07
seal fat 0,5 4,92 4,89 4,73 4,46 2,96 1,99 59,55
1 4,92 4,86 4,67 of 4.38 2,54 1,51 69,31
1,5 4,92 4,81 to 4.52 4,14 2,53 1,13 77,03

Continuation of table 2
1 2 3 4 5/td> 6 7 8 9 10
C. longum MM control 4,92 4,92 4,91 4,81 4,54 3,21 34,76
cedar oil 0,5 4,92 4,92 4,89 to 4.62 4,19 to 2.57 47,76
1 4,92 4,91 4,85 of 4.45 as 4.02 of 2.21 55,08
1,5 4,92 4,91 4,81 or 4.31 a 3.87 1,94 60,57
Flaxseed oil 0,5 4,92 4,92 4,85 4,53 4,14 2,47 49,8
1 4,92 4,91 4,79 to 4.41 3,95 2,02 58,94
1,5 4,92 4,91 4,74 or 4.31 3,86 1,63 66,87
fish oil 0,5 4,92 4,89 4,75 4,07 3,34 2,12 56,91
1 4,92 4,87 4,56 3,91 2,79 1,89 61,59
1,5 4,92 a 4.83 4,5 3,62 2,13 1,38 71,95
seal fat 0,5 4,92 a 4.9 4,81 4,56 3,45 2,25 54,27
1 4,92 4,89 4,78 to 4.52 2,91 1,93 60,77
1,5 4,92 4,87 4,63 4,24 2,68 1,51 69,31

As can be seen from the table.2, there is a high destruction of cholesterol in the cultivation process all strains of probiotic microorganisms. The cholesterol levels in the medium were determined by enzymatic method (see BALABINA M. D. Methods for the determination of cholesterol/M. D. BALABINA, centuries SLEPYSHEVA, A. C. KOZLOV//Hepatology-2004.-T6, No. 6.- S. 73-75; THE 9398-267-23548172-2002), based on the introduction into a nutrient medium in a person's blood.

Most cholesteroldegrading activity possesses Century Longum DK-100, which metabolizes 68,09% total cholesterol when making cedar oil, 74,39% - when making linseed oil, 79,07% - when adding fish oil and 77,03% - when making seal oil, respectively (Fig.3).

Thus, the obtained experimental data allow to conclude that the introduction of pine and flax oil, and fish and seal oil containing polyunsaturated fatty acids, increases cholesterolcholesterol properties and the number of viable cells of Bifidobacterium, which testifies to the growth of probiotic properties.

A comparative analysis of the assimilation of cholesterol are presented in table 3 (SHENDEROV B. A. Medical and microbial ecology and functional nutrition. Volume II: Socio economic and clinical consequences of the imbalance of the microbial ecology of humans and animals.- M: Publishing house of the GRANT,1998.-416 C.).

Table 3
Microorganisms The percentage of assimilation of cholesterol
Similar The proposed method
With cedar oil With linseed oil With fish oil With seal oil
B. longum KV8001 54,29
B. longum DK-100 68,09 74,39 79,07 77,03

The obtained results show that the cultivation of bacteria in a nutrient medium with the addition of 1.5% cedar or Flaxseed oil, fish or seal oil increases cholesterolcholesterol ability of bifidobacteria. Most high cholesterolcholesterol activity was observed in cultures with the addition of fish oil.

It should be noted that the BAA on the basis of probiotic microorganisms and cedar and Flaxseed oil, fish or seal oil in the literature was not found.

On the basis of the conducted researches optimal dose make cedar or Flaxseed oil, fish or seal oil in the amount of 1-1,5% of the volume of the nutrient medium, stimulating strong growth and viability of bifidobacteria. Also found that these bacterial concentrate the drugs have a high consumer properties: consistency homogeneous, without separation of serum; the taste and smell clean, sour taste of the respective added vegetable oil or animal fat; high holesterinesterzy activity and a high number of viable cells of Bifidobacterium.

Summarizing the obtained results, we can conclude that bifidobacteria bacterial concentrates with cedar or flax oil, fish or seal oil have a high biochemical high cholesterolcholesterol activity.

The inventive method is as follows.

As a nutrient medium for cultivation of bifidobacteria use clarified cheese whey, which is added growth components: a buffer salt, ascorbic acid, peptone, agar. Set the pH of the medium within (7±0,1). Then sterilized at 121°C for 30 minutes, cooled to a temperature of cultivation 36±1°C, make a 1-1,5% by weight of the cedar environment or flax oil, or fish or seal oil and 5% inoculum of the leaven of Bifidobacterium longum DK-100. Conduct capacity cells of bifidobacteria within 20-24 hours at double the neutralization environment through 10 hours to maintain the pH at an optimum level. Then separate the bacterial mass from the culture fluid. The obtained cell suspension is poured in aseptic condition is the conditions in sterile vials 12 cm 3, sealed, cooled to (4±2)°C.

The obtained liquid bacterial concentrate is used as a probiotic biologically active additives to food.

Example 1.As a nutrient medium for cultivation of bifidobacteria use clarified cheese whey, which is added growth components: a buffer salt, ascorbic acid, peptone, agar. Set the pH of the medium within (7±0,1). Then sterilized at 121°C for 30 minutes, cooled to a temperature of cultivation 36°C, contribute 1% cedar oil and 5% inoculum of the leaven of Bifidobacterium longum DK-100. Conduct capacity cells of bifidobacteria within 24 hours at double the neutralization environment through 10 hours to maintain the pH at an optimum level. Then separate the bacterial mass from the culture fluid. The obtained cell suspension is poured aseptically into sterile vials 12 cm3, sealed, cooled to (4±2)°C.

Example 2.As a nutrient medium for cultivation of bifidobacteria use clarified cheese whey, which is added growth components: a buffer salt, ascorbic acid, peptone, agar. Set the pH of the medium within (7±0,1). Then sterilized at 121°C for 30 minutes, cooled to a temperature of cultivation 36°C, make % linseed oil and 5% inoculum of the leaven of Bifidobacterium longum DK-100. Conduct capacity cells of bifidobacteria within 24 hours at double the neutralization environment through 10 hours to maintain the pH at an optimum level. Then separate the bacterial mass from the culture fluid. The obtained cell suspension is poured aseptically into sterile vials 12 cm3, sealed, cooled to (4±2)°C.

Example 3.As a nutrient medium for cultivation of bifidobacteria use clarified cheese whey, which is added growth components: a buffer salt, ascorbic acid, peptone, agar. Set the pH of the medium within (7±0,1). Then sterilized at 121°C for 30 minutes, cooled to a temperature of cultivation 36°C, contribute 1% fish oil and 5% inoculum of the leaven of Bifidobacterium longum DK-100. Conduct capacity cells of bifidobacteria within 24 hours at double the neutralization environment through 10 hours to maintain the pH at an optimum level. Then separate the bacterial mass from the culture fluid. The obtained cell suspension is poured aseptically into sterile vials 12 cm3, sealed, cooled to (4±2)°C.

Example 4.As a nutrient medium for cultivation of bifidobacteria use clarified cheese whey, which is added growth components: a buffer salt, as erbenova acid, peptone, agar. Set the pH of the medium within (7±0,1). Then sterilized at 121°C for 30 minutes, cooled to a temperature of cultivation 36°C, contribute 1% of seal fat and 5% inoculum of the leaven of Bifidobacterium longum DK-100. Conduct capacity cells of bifidobacteria within 24 hours at double the neutralization environment through 10 hours to maintain the pH at an optimum level. Then separate the bacterial mass from the culture fluid. The obtained cell suspension is poured aseptically into sterile vials 12 cm3, sealed, cooled to (4±2)°C.

Example 5.The use of liquid bacterial concentrate obtained according to examples 1-4, as probiotic biologically active additives to food.

The obtained liquid bacterial concentrates on examples 1-4 are used as probiotic dietary supplements to the diet to restore the microflora of the gastrointestinal tract, boost immunity and protect the body from cardiovascular diseases.

It is recommended to take an adult to 3 times a day, one teaspoon at meal times in four weeks.

1. A method of obtaining a bacterial concentrate, providing for the preparation of culture media, sterilization, cooling, making inoculum, the capacity of the cells, separating the bacteria is raise the weight from the culture fluid, the bottling, corking, characterized in that the composition of the nutrient medium contribute cedar or Flaxseed oil or fish or seal fat in the amount of 1-1,5% by weight of the medium as inoculum used Bifidobacterium Bifidobacterium longum DK-100.

2. The application of the bacterial concentrate obtained by the method according to p. 1 as probiotic biologically active food supplements.

 

© 2013-2015 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English.